These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31520209)

  • 1. Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment.
    Kim JW; Cho Y; Choi J; Ahn SG; Jeong J; Lee IJ
    Ann Surg Oncol; 2019 Dec; 26(13):4294-4301. PubMed ID: 31520209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of an Intraoperative Radiotherapy Program at a Safety net Hospital: What Is the Impact of an Intraoperative Radiotherapy Program in Underserved Patients With Early Breast Cancer?
    Lalchandani P; Sila C; Ozao-Choy J; Dauphine C
    Am Surg; 2021 May; 87(5):833-838. PubMed ID: 33228433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
    Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
    Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy.
    Mellon EA; Orman A; Joya LE; Montejo ME; Laronga C; Hoover SJ; Lee MC; Khakpour N; Kubal PF; Diaz R
    Brachytherapy; 2017; 16(1):174-180. PubMed ID: 27816540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Schoeber C; Schaefer J; Steil V; Wenz F
    BMC Cancer; 2007 Sep; 7():178. PubMed ID: 17854511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation.
    Horst KC; Fero KE; Ikeda DM; Daniel BL; Dirbas FM
    Radiother Oncol; 2013 Aug; 108(2):220-5. PubMed ID: 23597699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of failure to complete planned intraoperative breast radiation using the intrabeam® system.
    Dossett LA; Abbott AM; Sun W; Loftus L; Lee MC; Diaz R; Laronga C
    J Surg Oncol; 2016 Dec; 114(8):930-932. PubMed ID: 27861907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncoplastic breast-conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single-center experience.
    Crown A; Carlson E; Rocha FG; Grumley JW
    Breast J; 2020 Dec; 26(12):2391-2394. PubMed ID: 33283376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
    BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients.
    Reitsamer R; Peintinger F; Sedlmayer F; Kopp M; Menzel C; Cimpoca W; Glueck S; Rahim H; Kopp P; Deutschmann H; Merz F; Brandis M; Kogelnik H
    Eur J Cancer; 2002 Aug; 38(12):1607-10. PubMed ID: 12142049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural Community.
    Lorenzen AW; Kiriazov B; De Andrade JP; Lizarraga IM; Scott-Conner CE; Sugg SL; Erdahl LM; Sun W; Weigel RJ
    Ann Surg Oncol; 2018 Oct; 25(10):3004-3010. PubMed ID: 30030731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
    Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short term safety of oncoplastic breast conserving surgery for larger tumors.
    Wijgman DJ; Ten Wolde B; van Groesen NR; Keemers-Gels ME; van den Wildenberg FJ; Strobbe LJ
    Eur J Surg Oncol; 2017 Apr; 43(4):665-671. PubMed ID: 28041648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.
    Sperk E; Astor D; Keller A; Welzel G; Gerhardt A; Tuschy B; Sütterlin M; Wenz F
    Radiat Oncol; 2014 Jul; 9():154. PubMed ID: 25015740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy.
    Schiller DE; Le LW; Cho BC; Youngson BJ; McCready DR
    Ann Surg Oncol; 2008 Mar; 15(3):833-42. PubMed ID: 18163174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence.
    Sawaki M; Miyamoto T; Fujisawa T; Itoh Y; Ebara T; Tachibana H; Kodaira T; Kikumori T; Yanagita Y; Iwata H
    Ann Surg Oncol; 2019 Aug; 26(8):2428-2434. PubMed ID: 30993410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT.
    Meneveau MO; Petroni GR; Varhegyi NE; Hulse JC; Schroen AT; Brenin DR; Janowski EM; Berger AC; Lazar MA; Simone NL; Showalter TN; Showalter SL
    Brachytherapy; 2020; 19(5):679-684. PubMed ID: 32571746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.